3/19 TML-1209810
Because lung cancer is not a homogeneous disease...
for actionable mutations in mNSCLC
mNSCLC patients with BRAF V600 mutation
with TAFINLAR + MEKINIST to treat BRAF V600 mNSCLC
TAFINLARSummary of Product Characteristics
MEKINISTSummary of Product Characteristics
